AAO: Genentech provides update on presentations, product portfolio

Video
Conference|AAO

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.


Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of some of the company’s podium presentations from the Port Delivery System with ranibizumab to the novel pipeline molecule, faricimab.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Related Content
A lectern and podium, with three microphones, in front of the European Union (EU) flag. Concept image for Ophthalmology Times Europe editorial advisory board members presenting at American Academy of Ophthalmology meeting 2025. Image credit: ©corund – stock.adobe.com

AAO 2025: What the Eye Care Network's editorial advisory board members are presenting

Kassi Filkins
October 8th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

October 8th 2025
Podcast
A surgical tray sits on a dirt road. There are visible scalpels and other metal tools. Concept image for ocular trauma, conflict and combat zones, eye surgery and emergency ophthalmology in low-resource, high-conflict regions or war zones. Created by Jennifer Toomey using Adobe Firefly AI.

Clinicians keep their eyes on wartime ocular trauma

Oksana Vitovska, MD; Sibylle Scholtz, PhD;Hattie Hayes
October 8th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

October 8th 2025
Podcast
Two people sit at a table. Their hands are visible, as are computers, pencils, notebooks, clipboards and documents. Concept image for business merger, licensing partnership, work collaboration, commercialisation throughout Europe, Re-Vana Therapeutics and Boehringer Ingelheim ocular eye drug therapy. Image credit: ©NAMPIX – stock.adobe.com

Re-Vana Therapeutics and Boehringer Ingelheim announce collaboration, licensing partnership

Lynda Charters
October 8th 2025
Article
A row of beakers with yellow and orange fluid in a laboratory. Concept image for microbial lutein production, bioengineering, sustainable synthesis for cataract cornea age-related macular degeneration (AMD) and retinal disease. Image credit: bidala – stock.adobe.com

New microbial strain produces high yields of lutein for AMD, cataract prevention

Kassi Filkins
October 8th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.